AUM BioTech is a biotechnology company that offers antisense oligonucleotide solutions for biomedical research, including gene screening, target validation, and loss-of-function studies.

AUM’s next generation FANA Antisense Oligonucleotide (FANA ASO) Technology provides robust alternatives to CRISPR, siRNA and shRNA approaches. FANA ASOs can be used to silence or regulate RNA modalities such as – mRNA, microRNA and long non-coding RNA.

Some key features of FANA Antisense Oligonucleotides include:

• Self-Deliverable
• Does Not Require Transfection Reagents
• Single Step Protocol
• Rapid Protocol (1-3 days to analysis)
• In Vitro and In Vivo Applications
• Minimizes RNAi/CRISPR Related Off-Target Effects
• Robust Mode of Action

AUM’s FANA ASO Technology is used globally by scientists and researchers working on basic, transitional and preclinical research. AUM’s FANA ASO technology also provides next generation solutions for genetic research in agriculture and entomology.